New CEO appointed, three independent directors added, weak Q1 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.5 pts less than Nifty Microcap 250 and 4.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved Q1 FY27 results with total income of Rs 870.46 lakhs against Rs 891.88 lakhs in Q1 FY26, posting a marginal net profit of Rs 0.28 lakhs and EPS of Rs 0.00. Full year FY26 loss was Rs 111.72 lakhs. Dr Thanigai Vendan Moorrthy was appointed CEO in non-director capacity for five years. Three new independent directors were also appointed and the Audit Committee and Stakeholders Relationship Committee were reconstituted.
Leadership refresh with new CEO and independent directors may strengthen governance, but near break-even quarterly results show the hospital remains under financial pressure.